Ryan D. Maynard, EVP & CFO at RIGEL PHARMACEUTICALS INC (RIGL), sold 23,302 shares at $10.67 ($249K) on 2012-09-07, disclosed to the SEC on 2012-09-14.
Open-market sale of $249k RIGL by EVP & CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| IOVA | BUY | 2022-06-02 | $51K | — | Filing → |
| RIGL | SELL | 2017-11-07 | $390K | — | Filing → |
| RIGL | SELL | 2012-09-14 | $249K | — | Filing → |